Breakthrough mucormycosis after hematopoietic stem cell transplantation: a retrospective multiyear cohort study in Eastern China. (PubMed, Ann Clin Microbiol Antimicrob) - May 24, 2026 - "Mucormycosis poses a serious risk post-HSCT; early identification and optimized treatment are critical to improving outcomes."
Journal • Retrospective data • Acute Graft versus Host Disease • Bone Marrow Transplantation • Graft versus Host Disease • Hematological Malignancies • Immunology • Infectious Disease • Myelodysplastic Syndrome • Oncology • Transplantation
|
|
Baolin Tang; Guangyu Sun; Junjie Luo; Kaidi Song; Ke Yuan; Ping Qiang; Wen Yao; Xiang Wan; Xiaoyu Zhu
|